• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于黄酮类化合物控释的聚合物体系

Polymeric Systems for the Controlled Release of Flavonoids.

作者信息

Pecorini Gianni, Ferraro Elisabetta, Puppi Dario

机构信息

BIOLab Research Group, Department of Chemistry and Industrial Chemistry, University of Pisa, UdR INSTM Pisa, Via Moruzzi 13, 56124 Pisa, Italy.

Department of Biology, University of Pisa, S.S. 12 Abetone e Brennero 4, 56127 Pisa, Italy.

出版信息

Pharmaceutics. 2023 Feb 13;15(2):628. doi: 10.3390/pharmaceutics15020628.

DOI:10.3390/pharmaceutics15020628
PMID:36839955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9964149/
Abstract

Flavonoids are natural compounds that are attracting great interest in the biomedical field thanks to the wide spectrum of their biological properties. Their employment as anticancer, anti-inflammatory, and antidiabetic drugs, as well as for many other pharmacological applications, is extensively investigated. One of the most successful ways to increase their therapeutic efficacy is to encapsulate them into a polymeric matrix in order to control their concentration in the physiological fluids for a prolonged time. The aim of this article is to provide an updated overview of scientific literature on the polymeric systems developed so far for the controlled release of flavonoids. The different classes of flavonoids are described together with the polymers most commonly employed for drug delivery applications. Representative drug delivery systems are discussed, highlighting the most common techniques for their preparation. The flavonoids investigated for polymer system encapsulation are then presented with their main source of extraction and biological properties. Relevant literature on their employment in this context is reviewed in relationship to the targeted pharmacological and biomedical applications.

摘要

黄酮类化合物是天然化合物,由于其广泛的生物学特性,在生物医学领域引起了极大的关注。它们作为抗癌、抗炎和抗糖尿病药物以及许多其他药理应用的研究正在广泛开展。提高其治疗效果最成功的方法之一是将它们封装在聚合物基质中,以便在生理流体中长时间控制其浓度。本文的目的是提供关于迄今为止开发的用于黄酮类化合物控释的聚合物系统的科学文献的最新综述。描述了不同类别的黄酮类化合物以及药物递送应用中最常用的聚合物。讨论了代表性的药物递送系统,突出了其制备的最常见技术。然后介绍了研究用于聚合物系统封装的黄酮类化合物及其主要提取来源和生物学特性。就其在这种情况下的应用,结合靶向药理和生物医学应用对相关文献进行了综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/c77197680d97/pharmaceutics-15-00628-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/005aa1ddfe91/pharmaceutics-15-00628-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/fcbcb8001d79/pharmaceutics-15-00628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/4a6ebaae421b/pharmaceutics-15-00628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/d01131f6725b/pharmaceutics-15-00628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/8ec0ae3dd2a9/pharmaceutics-15-00628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/6b65d6fbfca6/pharmaceutics-15-00628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/5814bf58fe19/pharmaceutics-15-00628-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/f37b74b0e009/pharmaceutics-15-00628-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/a17403661feb/pharmaceutics-15-00628-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/b8a90f8c27be/pharmaceutics-15-00628-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/b87d6c4b36a7/pharmaceutics-15-00628-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/1575f69c74fd/pharmaceutics-15-00628-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/f83b0d543ea1/pharmaceutics-15-00628-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/e6e2ccb224e6/pharmaceutics-15-00628-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/1da5667bb78a/pharmaceutics-15-00628-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/a5c0c7f0c3f0/pharmaceutics-15-00628-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/f606ae96527d/pharmaceutics-15-00628-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/d96c59c1af0b/pharmaceutics-15-00628-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/9ed1f99c0130/pharmaceutics-15-00628-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/c77197680d97/pharmaceutics-15-00628-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/005aa1ddfe91/pharmaceutics-15-00628-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/fcbcb8001d79/pharmaceutics-15-00628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/4a6ebaae421b/pharmaceutics-15-00628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/d01131f6725b/pharmaceutics-15-00628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/8ec0ae3dd2a9/pharmaceutics-15-00628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/6b65d6fbfca6/pharmaceutics-15-00628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/5814bf58fe19/pharmaceutics-15-00628-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/f37b74b0e009/pharmaceutics-15-00628-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/a17403661feb/pharmaceutics-15-00628-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/b8a90f8c27be/pharmaceutics-15-00628-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/b87d6c4b36a7/pharmaceutics-15-00628-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/1575f69c74fd/pharmaceutics-15-00628-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/f83b0d543ea1/pharmaceutics-15-00628-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/e6e2ccb224e6/pharmaceutics-15-00628-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/1da5667bb78a/pharmaceutics-15-00628-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/a5c0c7f0c3f0/pharmaceutics-15-00628-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/f606ae96527d/pharmaceutics-15-00628-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/d96c59c1af0b/pharmaceutics-15-00628-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/9ed1f99c0130/pharmaceutics-15-00628-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/9964149/c77197680d97/pharmaceutics-15-00628-g020.jpg

相似文献

1
Polymeric Systems for the Controlled Release of Flavonoids.用于黄酮类化合物控释的聚合物体系
Pharmaceutics. 2023 Feb 13;15(2):628. doi: 10.3390/pharmaceutics15020628.
2
Critical Review of Biodegradable and Bioactive Polymer Composites for Bone Tissue Engineering and Drug Delivery Applications.用于骨组织工程和药物递送应用的可生物降解和生物活性聚合物复合材料的批判性综述
Polymers (Basel). 2021 Aug 6;13(16):2623. doi: 10.3390/polym13162623.
3
Electrospun polymeric micro/nanofibrous scaffolds for long-term drug release and their biomedical applications.用于长效药物释放的电纺聚合物微/纳米纤维支架及其生物医学应用。
Drug Discov Today. 2017 Sep;22(9):1351-1366. doi: 10.1016/j.drudis.2017.05.007. Epub 2017 May 24.
4
Natural biodegradable polymers based nano-formulations for drug delivery: A review.基于天然可生物降解聚合物的纳米制剂用于药物传递:综述。
Int J Pharm. 2019 Apr 20;561:244-264. doi: 10.1016/j.ijpharm.2019.03.011. Epub 2019 Mar 6.
5
Nanostructures for Delivery of Flavonoids with Antibacterial Potential against .用于递送具有抗菌潜力的类黄酮的纳米结构 针对……
Antibiotics (Basel). 2024 Sep 5;13(9):844. doi: 10.3390/antibiotics13090844.
6
Prevention of microbial biofilms - the contribution of micro and nanostructured materials.微生物生物膜的预防——微观和纳米结构材料的作用
Curr Med Chem. 2014;21(29):3311. doi: 10.2174/0929867321666140304101314.
7
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications.脂质-聚合物杂化纳米粒子:合成策略与生物医学应用。
J Microbiol Methods. 2019 May;160:130-142. doi: 10.1016/j.mimet.2019.03.017. Epub 2019 Mar 18.
8
Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).大分子拥挤现象:化学与物理邂逅生物学(瑞士阿斯科纳,2012年6月10日至14日)
Phys Biol. 2013 Aug;10(4):040301. doi: 10.1088/1478-3975/10/4/040301. Epub 2013 Aug 2.
9
Recent progress and challenges for polymeric microsphere compared to nanosphere drug release systems: Is there a real difference?聚合物微球与纳米球药物释放系统的最新进展和挑战:真有区别吗?
Bioorg Med Chem. 2021 Mar 1;33:116028. doi: 10.1016/j.bmc.2021.116028. Epub 2021 Jan 19.
10
Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids.现代纳米载体作为提高黄酮类化合物生物利用度和药理活性的一个因素。
Appl Biochem Microbiol. 2022;58(9):1002-1020. doi: 10.1134/S0003683822090149. Epub 2022 Dec 16.

引用本文的文献

1
Naringenin as a neurotherapeutic agent in Alzheimer's disease: epigenetic signatures, gut microbiota alterations, and molecular neuroprotection.柚皮素作为阿尔茨海默病的神经治疗剂:表观遗传特征、肠道微生物群改变和分子神经保护
Front Aging Neurosci. 2025 Aug 15;17:1647967. doi: 10.3389/fnagi.2025.1647967. eCollection 2025.
2
Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.异鼠李素:抗癌机制及纳米制剂驱动递送的最新进展综述
Int J Mol Sci. 2025 Jul 30;26(15):7381. doi: 10.3390/ijms26157381.
3
Multiple Strategies for the Application of Medicinal Plant-Derived Bioactive Compounds in Controlling Microbial Biofilm and Virulence Properties.

本文引用的文献

1
Modern Nanocarriers as a Factor in Increasing the Bioavailability and Pharmacological Activity of Flavonoids.现代纳米载体作为提高黄酮类化合物生物利用度和药理活性的一个因素。
Appl Biochem Microbiol. 2022;58(9):1002-1020. doi: 10.1134/S0003683822090149. Epub 2022 Dec 16.
2
The Flavone Cirsiliol from Binds the F Moiety of ATP Synthase, Modulating Free Radical Production.鸢尾黄素与 ATP 合酶的 F 亚基结合,调节自由基的产生。
Cells. 2022 Oct 9;11(19):3169. doi: 10.3390/cells11193169.
3
Therapeutic Potential and Pharmaceutical Development of a Multitargeted Flavonoid Phloretin.
药用植物衍生生物活性化合物在控制微生物生物膜和毒力特性中的多种应用策略
Antibiotics (Basel). 2025 May 29;14(6):555. doi: 10.3390/antibiotics14060555.
4
Flavonoid-Based Nanogels: A Comprehensive Overview.基于黄酮类化合物的纳米凝胶:全面综述。
Gels. 2025 Apr 4;11(4):267. doi: 10.3390/gels11040267.
5
Advances in research on flavonoids in tumor immunotherapy (Review).黄酮类化合物在肿瘤免疫治疗中的研究进展(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13515. Epub 2025 Apr 11.
6
Herbal remedies for oral and dental health: a comprehensive review of their multifaceted mechanisms including antimicrobial, anti-inflammatory, and antioxidant pathways.用于口腔和牙齿健康的草药疗法:对其多方面机制的全面综述,包括抗菌、抗炎和抗氧化途径。
Inflammopharmacology. 2025 Mar;33(3):1085-1160. doi: 10.1007/s10787-024-01631-8. Epub 2025 Feb 5.
7
Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for Ranolazine.代谢调节剂对小胶质细胞的抗炎重编程以对抗神经退行性变;雷诺嗪的新作用。
Sci Rep. 2023 Nov 17;13(1):20138. doi: 10.1038/s41598-023-47540-8.
8
From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds.从植物到伤口敷料及生物活性化合物的透皮递送
Plants (Basel). 2023 Jul 16;12(14):2661. doi: 10.3390/plants12142661.
9
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation.聚乳酸-乙醇酸纳米和微粒在递送调节炎症不同阶段的药物中的应用。
Pharmaceutics. 2023 Jun 20;15(6):1772. doi: 10.3390/pharmaceutics15061772.
多靶点类黄酮根皮素的治疗潜力与药物研发
Nutrients. 2022 Sep 2;14(17):3638. doi: 10.3390/nu14173638.
4
Xanthohumol exerts anti-inflammatory effects in an in vitro model of mechanically stimulated cementoblasts.黄腐酚在机械刺激成牙骨质细胞的体外模型中发挥抗炎作用。
Sci Rep. 2022 Sep 2;12(1):14970. doi: 10.1038/s41598-022-19220-6.
5
Chrysin alleviates lipopolysaccharide-induced neuron damage and behavioral deficits in mice through inhibition of Fyn.白杨素通过抑制 Fyn 减轻脂多糖诱导的小鼠神经元损伤和行为缺陷。
Int Immunopharmacol. 2022 Oct;111:109118. doi: 10.1016/j.intimp.2022.109118. Epub 2022 Aug 10.
6
Facile production of quercetin nanoparticles using 3D printed centrifugal flow reactors.使用3D打印离心流动反应器轻松制备槲皮素纳米颗粒。
RSC Adv. 2022 Jul 19;12(32):20696-20713. doi: 10.1039/d2ra02745c. eCollection 2022 Jul 14.
7
Nanotechnological exploitation of the antioxidant potential of Humulus lupulus L. extract.纳米技术对啤酒花提取物抗氧化潜力的开发利用。
Food Chem. 2022 Nov 1;393:133401. doi: 10.1016/j.foodchem.2022.133401. Epub 2022 Jun 6.
8
Anti-inflammatory and immunoregulatory effects of icariin and icaritin.朝藿定和朝藿苷的抗炎及免疫调节作用。
Biomed Pharmacother. 2022 Jul;151:113180. doi: 10.1016/j.biopha.2022.113180. Epub 2022 May 27.
9
Potential effects of icariin, the Epimedium-derived bioactive compound in the treatment of COVID-19: a hypothesis.淫羊藿素作为一种源自淫羊藿的生物活性化合物,在治疗 COVID-19 方面的潜在作用:一个假说。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Sep;395(9):1019-1027. doi: 10.1007/s00210-022-02262-y. Epub 2022 Jun 3.
10
Flavonoids-Based Delivery Systems towards Cancer Therapies.基于类黄酮的癌症治疗递送系统
Bioengineering (Basel). 2022 May 2;9(5):197. doi: 10.3390/bioengineering9050197.